ENDOLOGIX INC's ticker is and the CUSIP is 29266SAB2. A total of 14 filers reported holding ENDOLOGIX INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 1.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 3,400,000 | $2,939,000 | 1.97% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 40,500,000 | $35,030,000 | 1.58% |
| PFM Health Sciences, LP | 40,409,000 | $35,156,000 | 0.69% |
| Partner Investment Management, L.P. | 427,000 | $371,000 | 0.35% |
| LINDEN ADVISORS LP | 9,448,000 | $8,121,000 | 0.29% |
| SSI INVESTMENT MANAGEMENT LLC | 3,256,000 | $2,796,000 | 0.24% |
| AMUNDI ASSET MANAGEMENT US, INC. | 8,250,000 | $7,136,000 | 0.02% |
| Citadel Advisors | 18,560,000 | $15,866,000 | 0.01% |
| Jefferies Group LLC | 125,000 | $107,000 | 0.00% |
| Bank of New York Mellon Corp | 400,000 | $348,000 | 0.00% |